-
,for, Item ID-
- #171444
- Covidien #8886661841
Absorbable Suture with Needle Maxon™ Polyglyconate C-14 3/8 Circle Reverse Cutting Needle Size 3-0 Monofilament
SUTURE, MAXON CLR 3-0 30" CE-6/C-14 (36/BX)
Features
- MAXON™ and MAXON™ CV synthetic absorbable sutures are prepared from polyglyconate, a copolymer of glycolic acid and trimethylene carbonate
- MAXON™ and MAXON™ CV synthetic absorbable sutures are indicated for use in general soft tissue approximation and/or ligation, including use in pediatric cardiovascular tissue, where growth is expected to occur, and in peripheral vascular surgery
- MAXON™ and MAXON™ CV synthetic absorbable sutures are not indicated for use in adult cardiovascular tissue, ophthalmic surgery, microsurgery and neural tissues
- More …
Suture Size
Size 2-0 Size 3-0 Size 4-0Product Details Email
Product Specifications
McKesson # | 171444 |
---|---|
Manufacturer # | 8886661841 |
Brand | Maxon™ |
Manufacturer | Covidien |
Country of Origin | Unknown |
Application | Absorbable Suture with Needle |
Coating | Uncoated |
Needle 1 Code | C-14 |
Needle Length | 24 mm |
Needle Length Range | 20.1 to 40 mm |
Needle Material | Alloy Needle |
Needle Shape | 3/8 Circle |
Needle Type | Reverse Cutting Needle |
Number of Needles | 1-Needle |
Number of Strands | 36-Strand |
Sterility | Sterile |
Suture Color | Clear |
Suture Length | 30 Inch Suture |
Suture Length Range | 20.1 to 40 in |
Suture Material | Polyglyconate |
Suture Material Range | Undyed Synthetic |
Suture Size | Size 3-0 |
Suture Type | Monofilament |
UNSPSC Code | 42312201 |
WARNING: This product can expose you to chemicals which are known to the State of California to cause cancer and birth defects or other reproductive harm. For more information, go to www.p65Warnings.ca.gov.
Features
- MAXON™ and MAXON™ CV synthetic absorbable sutures are prepared from polyglyconate, a copolymer of glycolic acid and trimethylene carbonate
- MAXON™ and MAXON™ CV synthetic absorbable sutures are indicated for use in general soft tissue approximation and/or ligation, including use in pediatric cardiovascular tissue, where growth is expected to occur, and in peripheral vascular surgery
- MAXON™ and MAXON™ CV synthetic absorbable sutures are not indicated for use in adult cardiovascular tissue, ophthalmic surgery, microsurgery and neural tissues
- MAXON™ sutures retain approximately 75% of initial tensile strength at two weeks, 65% of at three weeks and 50% at four weeks post-implant
- Absorption of MAXON™ sutures is minimal until about 60 days after implant and is essentially complete within six months
- This product is required to be reported under California Proposition 65
More Information
Frequently Viewed Together
-
,for, Item ID-
- #501218
- Covidien #SMM-5526
-
,for, Item ID-
- #130602
- J & J Healthcare Systems #Z423H
-
,for, Item ID-
- #504615
- Covidien #SMM-5536
-
,for, Item ID-
- #171664
- Covidien #8886661231
-
,for, Item ID-
- #906040
- Surgical Specialties #Y494N
-
,for, Item ID-
- #481393
- Covidien #SC5689G
-
,for, Item ID-
- #171686
- Covidien #8886661241
-
,for, Item ID-
- #895370
- Surgical Specialties #Y497N
-
,for, Item ID-
- #171445
- Covidien #8886661851
-
,for, Item ID-
- #883177
- Surgical Specialties #Y496N
-
,for, Item ID-
- #564189
- Covidien #8886660841
-
,for, Item ID-
- #488906
- Covidien #SC5690G
-
,for, Item ID-
- #128893
- J & J Healthcare Systems #Z442H
-
,for, Item ID-
- #506676
- Covidien #SMM-5044
-
,for, Item ID-
- #492060
- Covidien #SC-5637-G
-
,for, Item ID-
- #166661
- Covidien #8886626751